Canopy Growth Corp Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Canopy Growth Corp (CGC) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 2.98% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-08-07
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2026-06-30 was 2.98%, a 9.16% increase year-over-year.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2025-06-30 was 2.73%, a 25.41% decline year-over-year.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2024-06-30 was 3.66%, a 4.44% decline year-over-year.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-06-30 was 3.83%, a 10.06% increase year-over-year.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2026 was 2.72%, a 20.93% decline from fiscal 2025.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 3.44%, a 10.18% decline from fiscal 2024.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 3.83%, a 11.01% increase from fiscal 2023.
- Canopy Growth Corp share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 3.45%, a 216.51% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.98% 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | 2.72% 10-K · filed 2026-06-15 | |||
| 2025-12-31 | 2.58% 10-Q · filed 2026-02-06 | |||
| 2025-09-30 | 2.64% 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | 2.73% 10-Q · filed 2026-08-07 | |||
| 2025-03-31 | 3.44% 10-K · filed 2026-06-15 | |||
| 2024-12-31 | 0.00% 10-Q · filed 2026-02-06 | |||
| 2024-09-30 | 3.00% 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | 3.66% 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | 3.83% 10-K · filed 2026-06-15 | |||
| 2023-12-31 | 3.95% 10-Q · filed 2025-02-07 | |||
| 2023-06-30 | 3.83% 10-Q · filed 2024-08-09 | |||
| 2023-03-31 | 3.45% 10-K · filed 2025-05-30 | |||
| 2022-12-31 | 3.47% 10-Q · filed 2023-02-09 | 3.47% 10-Q · filed 2024-02-09 | ||
| 2022-09-30 | 2.94% 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | 3.48% 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | 1.09% 10-K · filed 2024-05-30 | |||
| 2021-12-31 | 1.21% 10-Q · filed 2023-02-09 | 1.21% 10-Q · filed 2022-02-09 | ||
| 2021-06-30 | 0.67% 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | 0.36% 10-K · filed 2023-06-22 | |||
| 2020-12-31 | 0.49% 10-Q · filed 2022-02-09 | |||
| 2020-09-30 | 0.36% 10-Q · filed 2021-11-08 | 0.36% 10-Q · filed 2020-11-09 | ||
| 2020-06-30 | 0.33% 10-Q · filed 2020-08-10 | 0.33% 10-Q · filed 2021-08-06 | ||
| 2020-03-31 | 1.38% 10-K · filed 2022-05-31 | |||
| 2019-12-31 | 1.60% 10-Q · filed 2021-02-09 | |||
| 2019-09-30 | 1.44% 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | 1.41% 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | 2.00% 10-K · filed 2021-06-01 | |||
| 2018-03-31 | 1.54% 10-K · filed 2020-06-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |